TE_11699
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | LINC01339, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 192.17 |
| Counts of samples | TCGA_tumor:340; TCGA_normal:0; GTEx:1 |
| TSS | chr5(-):90208734 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_11699.1 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90153324,90153344,90189565,90189923,90208681,90208735 |
| teRNA_11699.2 | - | Intergenic | Non-coding | Non-coding | chr5(-):90138180,90138200,90208304,90208448,90208681,90208735 |
| teRNA_11699.3 | - | Intergenic | Non-coding | Non-coding | chr5(-):90189903,90189923,90208304,90208448,90208681,90208735 |
| teRNA_11699.4 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90153324,90153344,90208304,90208735 |
| teRNA_11699.5 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90158499,90158519,90160529,90160589,90208304,90208735 |
| teRNA_11699.6 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90160103,90160123,90160529,90160589,90208304,90208735 |
| teRNA_11699.7 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90160569,90160589,90208304,90208735 |
| teRNA_11699.8 | - | Intergenic | Non-coding | Non-coding | chr5(-):90189903,90189923,90208304,90208735 |
| teRNA_11699.9 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90153324,90153344,90189565,90189923,90208304,90208735 |
| teRNA_11699.10 | - | Intergenic | Non-coding | Non-coding | chr5(-):90138180,90138200,90208304,90208735 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
